Halozyme Therapeutics, Inc.
HALO
$47.91
-$2.32-4.62%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 25.47% | -10.54% | 25.95% | 14.15% | 37.93% |
| Total Receivables | -1.24% | 7.95% | 33.20% | 9.51% | -16.36% |
| Inventory | 16.22% | 7.95% | -17.51% | -5.48% | 32.08% |
| Prepaid Expenses | 14.55% | -10.49% | -48.76% | 85.89% | -6.01% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 16.28% | -3.69% | 14.09% | 13.07% | 17.04% |
|
|
|||||
| Total Current Assets | 16.28% | -3.69% | 14.09% | 13.07% | 17.04% |
| Net Property, Plant & Equipment | -2.96% | 0.73% | -0.68% | -3.93% | 4.17% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -4.42% | -4.23% | -4.06% | -3.90% | -3.76% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -28.01% | 5.36% | 52.72% | 192.62% | -19.22% |
| Total Assets | 6.45% | -2.58% | 7.54% | 6.95% | 6.25% |
|
|
|||||
| Total Accounts Payable | 95.86% | -17.33% | -19.65% | 15.80% | 12.77% |
| Total Accrued Expenses | 6.98% | 26.33% | 110.26% | -21.93% | -41.66% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -72.06% | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | 21.86% | -- |
| Total Other Current Liabilities | -- | -- | -- | 21.86% | -- |
| Total Current Liabilities | 8.11% | 27.83% | -18.41% | 1.31% | 17.02% |
|
|
|||||
| Total Current Liabilities | 8.11% | 27.83% | -18.41% | 1.31% | 17.02% |
| Long-Term Debt | 0.11% | 0.11% | 0.11% | 0.11% | 0.11% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 24.25% | -23.09% | 0.81% | -2.22% | -3.09% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -13.05% | 43.98% | 58.30% | -- | -- |
| Total Liabilities | 0.86% | 2.06% | -0.88% | 0.98% | 0.86% |
|
|
|||||
| Common Stock & APIC | 6,175.61% | -99.80% | 100.86% | 158.99% | 370.07% |
| Retained Earnings | 32.82% | -9.50% | 52.57% | 55.71% | 84.84% |
| Treasury Stock & Other | -189.14% | 155.18% | -235.54% | -39.17% | 83.98% |
| Total Common Equity | 32.56% | -19.63% | 56.42% | 62.77% | 112.16% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 32.56% | -19.63% | 56.42% | 62.77% | 112.16% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 32.56% | -19.63% | 56.42% | 62.77% | 112.16% |
|
|
|||||